Clinical trials
Phase 1 Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 11 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 6 |
| Recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 7 |
| Corcept Therapeutics | 5 |
| Pfizer | 5 |
| AstraZeneca | 4 |
| Enanta Pharmaceuticals, Inc | 4 |
| Bristol-Myers Squibb | 3 |
| Gilead Sciences | 3 |
| Altimmune, Inc. | 2 |
| Mirum Pharmaceuticals, Inc. | 2 |
| Rivus Pharmaceuticals, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 78 |
| Obesity | 13 |
| Fatty Liver | 9 |
| Hyperinsulinism | 7 |
| Insulin Resistance | 7 |
| Overweight | 7 |
| Prediabetic State | 6 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Liver Cirrhosis | 4 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.